Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens
- 1 October 2001
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 28 (8) , 743-751
- https://doi.org/10.1038/sj.bmt.1703207
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 20 references indexed in Scilit:
- Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemiaBone Marrow Transplantation, 2000
- Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignanciesBone Marrow Transplantation, 2000
- Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/ cyclophosphamide vs total body irradiation: a meta-analysisBone Marrow Transplantation, 1998
- Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantationBone Marrow Transplantation, 1997
- An improved limited sampling method for individualised busulphan dosing in bone marrow transplantation in childrenBone Marrow Transplantation, 1997
- Individualizing Drug Dosage RegimensTherapeutic Drug Monitoring, 1993
- Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacologyCancer Chemotherapy and Pharmacology, 1991
- Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantationCancer Chemotherapy and Pharmacology, 1989
- Amplification of human minisatellites by the polymerase chain reaction: towards DNA fingerprinting of single cellsNucleic Acids Research, 1988
- Optimal sampling times for pharmacokinetic experimentsJournal of Pharmacokinetics and Biopharmaceutics, 1981